表紙
市場調查報告書

乳癌診斷檢驗:醫療設備的開發平台評估

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 404485
出版日期 內容資訊 英文 420 Pages
訂單完成後即時交付
價格
乳癌診斷檢驗:醫療設備的開發平台評估 Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 420 Pages
簡介

本報告提供全球乳癌診斷檢驗相關市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,加上產品特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 乳癌診斷檢驗概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 乳癌診斷檢驗:各企業現在臨床實驗中的開發中產品

  • 乳癌診斷檢驗的企業:各臨床實驗階段的開發中產品
  • 乳癌診斷檢驗:各臨床實驗階段的開發中產品

第5章 乳癌診斷檢驗的企業·產品概要

  • A&G Pharmaceutical Inc
  • Abbott Diagnostics
  • Abviva, Inc.
  • Accelerated Medical Diagnostics
  • Acobiom
  • Affichem SA
  • AIT Austrian Institute of Technology GmbH
  • Albert-Ludwigs-Universitat Freiburg
  • Almac Diagnostics Ltd
  • Amarantus Bioscience Holdings Inc
  • AngioGenex Inc
  • Anixa Diagnostics Corporation
  • Armune BioScience, Inc.
  • Arno Therapeutics Inc
  • ArtemixRx
  • Ascendant Diagnostics, LLC
  • Assurance Biosciences, Inc. (Inactive)
  • Atossa Genetics, Inc.
  • Aurelium BioPharma Inc.
  • Autoimmune Technologies LLC
  • Ayanda Biosystems SA (Inactive)
  • Baylor College of Medicine
  • BCAL Diagnostics Pty Limited
  • Becton Dickinson and Company
  • Biocartis SA Company Overview
  • Biocrates Life Sciences AG
  • Biodesix Inc
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Bio-Techne Corp
  • bioTheranostics Inc
  • BioTime Inc
  • Caprion Biosciences Inc
  • Cellanyx Diagnostics, Inc.
  • CellMax Life
  • CellXplore, Inc.
  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
  • Cepheid
  • Ceres Nanosciences Inc
  • Cernostics Inc.
  • China Sky One Medical Inc
  • Chronix Biomedical Inc
  • Clarient Inc
  • Cleveland Diagnostics Inc.
  • CompanDX Ltd.
  • Courtagen Life Sciences Inc
  • CS-Keys, Inc.
  • Da An Gene Co Ltd
  • Dana-Farber Cancer Institute Inc
  • Dartmouth College
  • Diaxonhit SA
  • Dublin City University
  • Emergence BioScreening, LLC
  • Eventus Diagnostics Inc (Inactive)
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • Fina Biotech
  • Fluxion Biosciences, Inc.
  • Fournira Optime Diagnostics
  • French National Institute of Health and Medical Research
  • GeneNews Ltd
  • Genentech Inc
  • GenomicTree Inc
  • Genoptix Inc
  • George Washington University
  • German Cancer Research Center
  • Ghent University
  • GlycoZym
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hai Kang Life Corp Ltd
  • Health Discovery Corp
  • Hebrew University of Jerusalem
  • Heragen, Inc.
  • Hummingbird Diagnostics GmbH
  • Ikonisys Inc
  • IncellDx Inc
  • Innovative Health Diagnostics
  • Insight Genetics Inc
  • Institute of Cancer Research
  • Inverness Medical Canada Inc. (Inactive)
  • IRIS International, Inc.
  • ITUS Corporation
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Jonakee Cancer Research, Inc.
  • Kailos Genetics, Inc.
  • Kalgene Pharmaceuticals Inc.
  • Leica Biosystems GmbH
  • Louisville Bioscience, Inc.
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Medical Prognosis Institute A/S
  • MEDITE Cancer Diagnostics Inc
  • MedMira Inc.
  • Metabolomic Technologies Inc
  • MetaStat Inc
  • Milagen, Inc.
  • MiRXES Pte Ltd
  • Molecular Warehouse Ltd
  • Myriad Genetics Inc
  • NanoString Technologies Inc
  • National University of Ireland, Galway
  • New York University
  • Newcastle University
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc. (Inactive)
  • Nuvera Biosciences Inc
  • Olink Proteomics AB
  • Olympia Diagnostics, Inc
  • Onconome, Inc. (Inactive)
  • OncoStem Diagnostics Pvt. Ltd
  • OncoVista Innovative Therapies Inc
  • On-Q-ity, Inc. (Inactive)
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Impedance Diagnostics Ltd
  • PeriRx LLC
  • Power3 Medical Products, Inc.
  • Precision Biologics Inc
  • PreMD Inc
  • Princeton University
  • Proplex Technologies Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomika
  • Provista Diagnostics Inc.
  • Qiagen NV
  • Quest Diagnostics Inc
  • Rna Diagnostics Inc.
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • Royal College of Surgeons in Ireland
  • RWTH Aachen University
  • Savicell Diagnostic Ltd.
  • Selventa Inc
  • Sengenics International Pte Ltd
  • Siamab Therapeutics Inc
  • Siemens Healthcare GmbH
  • Soricimed Biopharma Inc
  • Target Discovery, Inc.
  • Taxor Diagnostics, LLC
  • TechnoGenesys, Inc.
  • The University of Texas MD Anderson Cancer Center
  • Todos Medical
  • Trinity College Dublin
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alberta
  • University of Bonn
  • University of California Riverside
  • University of California San Diego
  • University of Chicago
  • University of Colorado
  • University of Iowa
  • University of Maryland, Baltimore
  • University of Nebraska
  • University of Oxford
  • University of South Florida
  • University of Wisconsin Madison
  • US Biomarkers Inc
  • Vermillion Inc
  • Viomics Inc.
  • Vitatex Inc.
  • Vitruvian Biomedical, Inc.
  • VolitionRX Ltd
  • XEPTAGEN SpA
  • Xiamen Zeesan Biotech Co.,Ltd
  • Zetiq Technologies Ltd

第6章 乳癌診斷檢驗市場:目前的趨勢 (全46件)

第7章 建議

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1024EPD

GlobalData's Medical Devices sector report, "Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Breast Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Breast Cancer Overview

3 Products under Development

  • 3.1 Breast Cancer - Pipeline Products by Stage of Development
  • 3.2 Breast Cancer - Pipeline Products by Territory
  • 3.3 Breast Cancer - Pipeline Products by Regulatory Path
  • 3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
  • 3.5 Breast Cancer - Ongoing Clinical Trials

4 Breast Cancer - Pipeline Products under Development by Companies

  • 4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Breast Cancer - Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

List of Tables

List of Tables

  • Table 1: Breast Cancer - Pipeline Products by Stage of Development
  • Table 2: Breast Cancer - Pipeline Products by Territory
  • Table 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Table 4: Breast Cancer - Pipeline Products by Estimated

List of Figures

List of Figures

  • Figure 1: Breast Cancer - Pipeline Products by Stage of Development
  • Figure 2: Breast Cancer - Pipeline Products by Territory
  • Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Breast Cancer - Ongoing Clinical Trials